RenovoRx RNXT
NASDAQ RNXT
$1.77 -0.23 (-11.32%)
As of: Sep 10, 2026 · 2:57 PM EDT

RenovoRx (RNXT) FCF Margin Growth (1y) (2026)

Analysis

RenovoRx (RNXT) FCF Margin Growth (1y) (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (1y) (Qtr)
1 Abbott Laboratories 180.77 Bn 175.17 Bn 7.27 Bn 194.00
2 Intuitive Surgical 127.65 Bn 122.43 Bn 1.96 Bn 984.00
3 Medtronic 117.15 Bn 108.33 Bn 6.34 Bn 641.00
4 Stryker 104.21 Bn 100.73 Bn 4.50 Bn 66.00
5 Boston Scientific 63.46 Bn 62.92 Bn 3.85 Bn 119.00
6 Edwards Lifesciences 49.73 Bn 45.48 Bn 1.35 Bn 1,788.00
7 Alcon 33.01 Bn 31.56 Bn 1.68 Bn -177.00
8 Dexcom 32.17 Bn 30.22 Bn 830.00 Mn -395.00
9 Steris 20.72 Bn 20.24 Bn 684.20 Mn -473.00
10 RenovoRx 84.43 Mn 84.43 Mn 766,000.00 20,809.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 20,809.00
Mar 31, 2026 105,847.00